A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study.
The Lancet regional health. Western Pacific（2023）
Abstract
New Terrain Biotechnology, Inc., Tianjin, China.
MoreTranslated text
Key words
myasthenia gravis,autoantibody diagnostic assays,double-blind
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined